Researchers to Investigate Genetic Variants Associated with Rare Pediatric Diseases MENLO PARK, Calif., Dec. 6, 2022 /PRNewswire/ — PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced…
MENLO PARK, Calif., Nov. 11, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the following…
MENLO PARK, Calif., Nov. 7, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2022. Third quarter results Revenue of $32.3 million, a…
World Class Team Will Provide Strategic Guidance and Direction for PacBio’s Research and Development Activities MENLO PARK, Calif., Nov. 2, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of…
Significant Advances in SMRT Cell Design, Compute, and a New System Architecture Will Enable Revio to Dramatically Increase Throughput and Lower Cost While Leveraging the Power of HiFi for Exceptional…
The Onso Sequencing System is Designed to Deliver Industry-Leading Sensitivity and Specificity for Novel Insights in Oncology and Disease Research This release is available in Japanese, Chinese and Korean…
Withdraws Guidance with New Product Announcement MENLO PARK, Calif., Oct. 25, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its…
MAS-Seq Supports Isoform Research Using Single-Cell RNA Sequencing from 10x Genomics This press releases is also available in Chinese , Japanese and Korean. MENLO PARK, Calif., Oct. 20, 2022 /PRNewswire/…
Alliance panels include a 50-gene pharmacogenomics panel and a nearly 400-gene panel of challenging, medically relevant “dark genes” developed in collaboration with leading institutions This press release is also…
The Consortium Will Build a Publicly Available Database as a Resource to Accelerate Insights from Long-Read Human Genome Datasets This release is available in Chinese MENLO PARK, Calif., Oct. 18,…
Analysis Method Supports Research on the Genetic Causes of Common Diseases MENLO PARK, Calif., Sept. 27, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,…
MENLO PARK, Calif., Sept. 7, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the upcoming…
MENLO PARK, Calif., Aug. 19, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that the Compensation Committee of the Company’s Board…
MENLO PARK, Calif., Aug. 5, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB) announced today that it will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit in Dana…
MENLO PARK, Calif., Aug. 3, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2022. Second quarter results Revenue of $35.5 million, a…
Clear filters
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.